ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.
Metrics to compare | 237690 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship237690PeersSector | |
|---|---|---|---|---|
P/E Ratio | 58.5x | 15.1x | −0.4x | |
PEG Ratio | 1.10 | 0.01 | 0.00 | |
Price/Book | 5.4x | 1.2x | 2.6x | |
Price / LTM Sales | 9.7x | 0.8x | 3.2x | |
Upside (Analyst Target) | 14.9% | 33.3% | 46.7% | |
Fair Value Upside | Unlock | 13.8% | 7.6% | Unlock |